Kirsti M. Jakobs (Netherlands)

Radboudumc Primary care and community care
General practitioner since 2001, with expertise on cardiovascular diseases since 2014 (kaderarts HVZ). I am a medical adviser for care group 'Onze Huisartsen' in the region of Arnhem and responsible for the cardiovascular risk management (CVRM) programme. GPs invite their patients with a high cardiovascular risk to receive annual check-ups and to improve risk factors. In this job I noticed that there seemed to be room for improvement for patients with a severe mental disease (SMI). The numbers of participants with SMI in the programme seemed low. I started as a PhD student to explore this problem. Now I'm working on the TACTIC project: Transmural collaborative care model for cardiovascular risk management and medication review for patients using antipsychotics: feasibility and evaluation study Published articles: Cardiovascular risk management in patients using antipsychotics: it is time to take action 2 Nov. 2020 BMC Medicine Cardiovascular risk screening of patients with serious mental illness or use of antipsychotics in family practice 29 Jul. 2020 BMC-FP

Author Of 1 Presentation

CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH SEVERE MENTAL ILLNESS OR TAKING ANTIPSYCHOTIC TREATMENTS: BARRIERS AND FACILITATORS AMONG DUTCH GENERAL PRACTITIONERS

Date
08.07.2021, Thursday
Session Time
05:30 PM - 07:00 PM
Room
Hall 6
Lecture Time
05:30 PM - 05:41 PM
Session Icon
Pre-Recorded with Live Q&A

Abstract

Abstract Body

Background and purpose

Patients with severe mental illness (SMI) or receiving treatment with antipsychotics (APs) have an increased risk of cardiovascular disease. Annual screening of their cardiovascular risk (CVR) increasingly depends on general practitioners (GPs) because of the shift of mental healthcare from secondary to primary care and the surge of off-label AP prescriptions. Nevertheless, the uptake of patients with SMI/APs in cardiovascular risk management programmes in Dutch primary care is low.

The purpose was to explore the barriers and facilitators perceived by GPs to perform CVR screening in patients with SMI or receiving APs.

Methods

A qualitative interview study among Dutch GPs. Barriers and facilitators were explored by individual in-depth, semi-structured interviews using a computer-generated list of eligible patients with SMI or APs but without annual CVR screening. Data were analysed thematically.

Results

The main barriers were: (i) underestimation of patient CVR and ambivalence to apply risk-lowering strategies such as smoking cessation, (ii) disproportionate burden on GPs in deprived areas, (iii) poor information exchange between GPs and psychiatrists, and (iv) scepticism about patient compliance, especially those with more complex conditions. The main facilitators included: (i) support of GPs through the use of a computer-generated list of eligible patients and (ii) involvement of family or carers.

Conclusions

This study indicates the preconditions required to facilitate GP inclusion of this specific population in primary care CVR management programmes, namely adequate recommendations in practice guidelines, improved consultation opportunities with psychiatrists, practical advice to support patient adherence, and incentives for practices in deprived areas.

Hide

Presenter of 1 Presentation

CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH SEVERE MENTAL ILLNESS OR TAKING ANTIPSYCHOTIC TREATMENTS: BARRIERS AND FACILITATORS AMONG DUTCH GENERAL PRACTITIONERS

Date
08.07.2021, Thursday
Session Time
05:30 PM - 07:00 PM
Room
Hall 6
Lecture Time
05:30 PM - 05:41 PM
Session Icon
Pre-Recorded with Live Q&A

Abstract

Abstract Body

Background and purpose

Patients with severe mental illness (SMI) or receiving treatment with antipsychotics (APs) have an increased risk of cardiovascular disease. Annual screening of their cardiovascular risk (CVR) increasingly depends on general practitioners (GPs) because of the shift of mental healthcare from secondary to primary care and the surge of off-label AP prescriptions. Nevertheless, the uptake of patients with SMI/APs in cardiovascular risk management programmes in Dutch primary care is low.

The purpose was to explore the barriers and facilitators perceived by GPs to perform CVR screening in patients with SMI or receiving APs.

Methods

A qualitative interview study among Dutch GPs. Barriers and facilitators were explored by individual in-depth, semi-structured interviews using a computer-generated list of eligible patients with SMI or APs but without annual CVR screening. Data were analysed thematically.

Results

The main barriers were: (i) underestimation of patient CVR and ambivalence to apply risk-lowering strategies such as smoking cessation, (ii) disproportionate burden on GPs in deprived areas, (iii) poor information exchange between GPs and psychiatrists, and (iv) scepticism about patient compliance, especially those with more complex conditions. The main facilitators included: (i) support of GPs through the use of a computer-generated list of eligible patients and (ii) involvement of family or carers.

Conclusions

This study indicates the preconditions required to facilitate GP inclusion of this specific population in primary care CVR management programmes, namely adequate recommendations in practice guidelines, improved consultation opportunities with psychiatrists, practical advice to support patient adherence, and incentives for practices in deprived areas.

Hide